LONDON and NEW YORK, July 28, 2023 -- OKYO Pharma Limited , an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease to address the significant...

Related Keywords

London , City Of , United Kingdom , New York , United States , Paul Spencer , Garys Jacob , Exchange Commission , Pharma Limited Nasdaq , Globenewswire Inc , Chief Executive , Markets ,